The current findings demonstrate that sensitization and challenges with OVA significantly elevated CRP levels compared to the control group (A: 978.3 ± 96.8 μg/mL vs. C: 413.2 ± 117.7 μg/mL, p < 0.001), suggesting that CRP could serve as a marker for systemic inflammation in allergic asthma. This evidence concerns the gene CRP and allergic asthma.